Effectiveness of early administration of tranexamic acid in patients with severe trauma

British Journal of Surgery

Volumn 104, Issue 6, 2017, Pages 710-717

  Shiraishi, A ^a,b   Kushimoto, S ^e   Otomo, Y ^b   Matsui, H ^a,c   Hagiwara, A ^d   Murata, K ^b   Hayakawa, M ^f   Maekawa, K ^f   Saitoh, D ^g   Ogura, H ^h   Sasaki, J ⁱ   Shibusawa, T ⁱ   Uejima, T ^j   Yaguchi, A ^k   Takeda, M ^k   Ishikura, H ^l   Nakamura, Y ^l   Kudo, D ^e   Kaneko, N ^m   Matsuoka, T ⁿ   Hagiwara, Y ⁿ   Morimura, N ^o   Furugori, S ^o   Kato, H ^p   Kanemura, T ^p   Mayama, G ^d   Kim, S ^q   Takasu, O ^r   Nishiyama, K ^s   more..

^a KAMEDA MEDICAL CENTER   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^e TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^g NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^h OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^l FUKUOKA UNIVERSITY   (Japan)

^m Fukaya Red Cross Hospital   (Japan)

ⁿ Rinku General Medical Center   (Japan)

^o YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^p NATIONAL HOSPITAL ORGANIZATION   (Japan)

^q NIPPON MEDICAL SCHOOL   (Japan)

^r KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^s JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; TRANEXAMIC ACID;

ADULT; AGED; BLOOD TRANSFUSION; BRAIN INJURIES; CLINICAL TRIAL; FEMALE; HEMORRHAGE; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROPENSITY SCORE; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ADULT; AGED; ANTIFIBRINOLYTIC AGENTS; BLOOD TRANSFUSION; BRAIN INJURIES; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PROPENSITY SCORE; RETROSPECTIVE STUDIES; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 85013647879     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.10497     Document Type: Article

References (31)

1. Okamoto S, Hijikata-Okunomiya A, Wanaka K, Okada Y, Okamoto U. Enzyme controlling medicines: introduction. Semin Thromb Hemost 1997; 23: 493–501.
2. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011; (1)CD001886.
3. CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376: 23–32.
4. CRASH-2 collaborators, Roberts I, Shakur H, Afolabi A, Brohi K, Coats T et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377: 1096–1101.
5. Cap AP, Baer DG, Orman JA, Aden J, Ryan K, Blackbourne LH. Tranexamic acid for trauma patients: a critical review of the literature. J Trauma 2011; 71(Suppl): S9–S14.
6. Napolitano LM, Cohen MJ, Cotton BA, Schreiber MA, Moore EE. Tranexamic acid in trauma: how should we use it? J Trauma Acute Care Surg 2013; 74: 1575–1586.
7. Valle EJ, Allen CJ, Van Haren RM, Jouria JM, Li H, Livingstone AS et al. Do all trauma patients benefit from tranexamic acid? J Trauma Acute Care Surg 2014; 76: 1373–1378.
8. Cole E, Davenport R, Willett K, Brohi K. Tranexamic acid use in severely injured civilian patients and the effects on outcomes: a prospective cohort study. Ann Surg 2015; 261: 390–394.
9. Harvin JA, Peirce CA, Mims MM, Hudson JA, Podbielski JM, Wade CE et al. The impact of tranexamic acid on mortality in injured patients with hyperfibrinolysis. J Trauma Acute Care Surg 2015; 78: 905–909.
10. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) study. Arch Surg 2012; 147: 113–119.
11. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70: 41–55.
12. Elm von E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453–1457.
13. Venables WN, Ripley BD. Modern Applied Statistics with S. Springer: New York, 2002.
14. Fox J, Weisberg W. An R Companion to Applied Regression. Sage: Thousand Oaks, 2011.
15. van Buuren S, Groothuis-Oudshoorn K. mice: multivariate imputation by chained equations in R. Journal of Statistical Software 2011; 45: 1–67.
16. Sekhon JS. Multivariate and propensity score matching software with automated balance optimization: the matching package for R. Journal of Statistical Software 2011; 42: 1–52.
17. Harrell FE Jr. RMS: Regression Modeling Strategies. R Package Version 4.4.1. https://CRAN.R-project.org/package=rms [accessed 29 June 2016].
18. Kleiber C, Zeileis A. Applied Econometrics with R. Springer: New York, 2008.
19. Robitzsch A. Miceadds: Some Additional Multiple Imputation Functions, Especially for ‘Mice’. R Package Version 1.5.0. https://CRAN.R-project.org/package=miceadds [accessed 29 June 2016].
20. Rubin DB. Inference and missing data. Biometrika 1976; 63: 581–592.
21. Rubin DB. Multiple Imputation for Nonresponse in Surveys. J. Wiley & Sons: New York, 1987.
22. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. CRC Press: Boca Raton, 1993.
23. Normand ST, Landrum MB, Guadagnoli E, Ayanian JZ, Ryan TJ, Cleary PD et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 2001; 54: 387–398.
24. Ilhan MN, Durukan E, Ilhan SO, Aksakal FN, Ozkan S, Bumin MA. Self-medication with antibiotics: questionnaire survey among primary care center attendants. Pharmacoepidemiol Drug Saf 2009; 18: 1150–1157.
25. Moore HB, Moore EE, Gonzalez E, Chapman MP, Chin TL, Silliman CC et al. Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy. J Trauma Acute Care Surg 2014; 77: 811–817.
26. Moore EE, Moore HB, Gonzalez E, Chapman MP, Hansen KC, Sauaia A et al. Postinjury fibrinolysis shutdown: rationale for selective tranexamic acid. J Trauma Acute Care Surg 2015; 78(Suppl 1): S65–S69.
27. CRASH-2 Collaborators (Intracranial Bleeding Study). Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study). BMJ 2011; 343: d3795.
28. Yutthakasemsunt S, Kittiwatanagul W, Piyavechvirat P, Thinkamrop B, Phuenpathom N, Lumbiganon P. Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial. BMC Emerg Med 2013; 13: 20.
29. Eckert MJ, Wertin TM, Tyner SD, Nelson DW, Izenberg S, Martin MJ. Tranexamic acid administration to pediatric trauma patients in a combat setting: the Pediatric Trauma and Tranexamic Acid study (PED-TRAX). J Trauma Acute Care Surg 2014; 77: 852–858.
30. Dewan Y, Komolafe EO, Mejía-Mantilla JH, Perel P, Roberts I, Shakur H; CRASH-3 Collaborators. CRASH-3 – tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial. Trials 2012; 13: 87.
31. Roberts I, Preto-Merino D, Manno D. Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial. Crit Care 2014; 18: 685.